FDA Patient Experience Data Guidance Needs Labeling Details, Drugmakers Say

Drug Industry Daily
A A
In comments on the first of four FDA patient experience data guidances, Allergan and Roche urged the agency to add more details on data that can be used in labeling.

To View This Article:

Login

Subscribe To Drug Industry Daily